The first trials of the third phase of the inactive Covid-19 vaccine in the UAE have achieved an achievement as it is one of the largest experiences in the world in mobilizing volunteer efforts, as it was able to attract more than 31,000 volunteers belonging to more than 120 nationalities. In just six weeks.
The “For Humanity” campaign recorded a qualitative achievement in terms of speed and efficiency in registering volunteers, examining and sharing the experiments of the inactive vaccine developed by “Synopharma CNBG”, a world leader in vaccine manufacture, which is managed by “G42 Healthcare” from its center. In Abu Dhabi, in partnership with the Department of Health – Abu Dhabi, the UAE Ministry of Health and Prevention, and the Abu Dhabi Health Services Company, “SEHA”.
Moving forward, thousands of volunteers have already received their second dose of the vaccine and will continue to undergo medical examinations and regular supervision, in addition to receiving full support from health services in order to ensure that they enjoy health and wellness.
With the arrival of these numbers of volunteers, ADNEC centers in Abu Dhabi and Al-Qareen in Sharjah will be closed to new volunteers, but the two centers will remain open to individuals who will receive their second dose of the vaccine and who will undergo the required medical examinations within the framework of the program according to the protocols and schedules set for volunteers.
The Department of Health – Abu Dhabi confirmed that sufficient numbers of volunteers required to complete the clinical trials have been reached. Therefore, new volunteer registration will be stopped as of Sunday, August 30th.
His Excellency Sheikh Abdullah bin Muhammad Al Hamed, Chairman of the Department of Health – Abu Dhabi, said: “This achievement would not have been possible without the support of our wise leadership of scientific research in the health care sector .. This is a truly distinguished achievement in this sector that will strengthen the UAE’s leading position at the forefront of research efforts. Global epidemic control. “
On behalf of the Abu Dhabi Health Department, His Excellency expressed his sincere gratitude to the volunteers who showed great enthusiasm to participate in clinical trials to achieve good for all humanity and to serve the state and its society in general, praising at the same time the medical staff of Abu Dhabi Health Services Company / Health / during the previous period and their continuous efforts to achieve this Target.
The Abu Dhabi Health Department said that it will continue to follow up the volunteers’ condition in accordance with the approved protocols for this study through contacts or direct interviews with the medical team.
In celebration of this national achievement, the Ministry of Health and Community Protection, the Department of Health – Abu Dhabi, Abu Dhabi Health Services Company, “Sinopharma” and the “G42 Healthcare” company expressed their thanks to all volunteers for their service to humanity and the clinical, technical and administrative staff for their work .. Thanks to their commitment and participation in these historical experiences, the world is taking a major step towards achieving the first safe and tested vaccine. “
Commenting on achieving access to more than 31,000 volunteers, His Excellency Abdul Rahman bin Muhammad Al Owais, Minister of Health and Community Protection, said: “The wise leadership in the UAE has been fully committed to combating the Covid-19 epidemic from the beginning through international cooperation efforts … It is enjoyed by UAE citizens and residents, and their willingness to volunteer is a living testament to the proactive approach adopted by the country as part of the world-leading program for experiments on the inactive vaccine. “
He added, “All those who participated in the experiments, starting from volunteers and passing through the clinical and administrative services staff, are entitled to be proud of what they have achieved so far, and this reflects the feelings of unity and endeavors towards achieving the common goals that the UAE and its inhabitants have always exhibited over the past five decades.”
The two inactive vaccines were successful in the first and second stages of the trials without causing any side effects, as 100 percent of the volunteers were able to generate antibodies.
The size of the volunteer numbers would make the program on a par with similar experiment programs that are internationally recognized, in which the numbers of participants include about 45 thousand volunteers or more.
The trials phase comes within the framework of a series of national initiatives that aim to improve the health of the population and support medical research and development capabilities in the country, and this includes strengthening local capabilities to manufacture the vaccine.